rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kathryn Michelle Armstrong

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, USANA Health Sciences.

In numbers

Trades disclosed
18
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
27 Feb 2025
Last trade
25 Jul 2026
Last filed
27 Jul 2026

Companies traded

Where they are an officer
USNA USANA Health SciencesOfficer · Pharmaceuticals · last 25 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
25 Jul 2026filed 27 Jul 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,166filing
25 Jul 2026filed 27 Jul 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code F$11K518 at $21.32filing
25 Jul 2026filed 27 Jul 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,166 at $0.00filing
25 Jul 2026filed 27 Jul 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,166 at $0.00filing
25 Jul 2026filed 27 Jul 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,166filing
25 Jul 2026filed 27 Jul 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code F$11K518 at $21.32filing
27 Feb 2026filed 3 Mar 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—4,190filing
27 Feb 2026filed 3 Mar 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code F$43K2,015 at $21.52filing
27 Feb 2026filed 3 Mar 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—4,190 at $0.00filing
27 Feb 2026filed 3 Mar 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—4,190 at $0.00filing
27 Feb 2026filed 3 Mar 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—4,190filing
27 Feb 2026filed 3 Mar 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code F$43K2,015 at $21.52filing
19 Feb 2026filed 23 Feb 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—24,526 at $0.00filing
19 Feb 2026filed 23 Feb 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—24,526 at $0.00filing
25 Jul 2025filed 28 Jul 2025USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,165 at $0.00filing
25 Jul 2025filed 28 Jul 2025USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,165filing
25 Jul 2025filed 28 Jul 2025USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code F$17K517 at $31.95filing
27 Feb 2025filed 3 Mar 2025USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—16,760 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

J. Scott NixonDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
Gilbert A. FullerDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
Timothy E. WoodDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
Xia DingDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
John Turman FlemingDirector · Director at Usana Health Sciences, filing Form 4 there in the last year